ISO 14155:2020 is a globally recognized standard that governs good clinical practices for medical device clinical investigations involving human subjects. It is applicable to manufacturers, sponsors, clinical research organizations (CROs), and investigators engaged in medical device testing for pre-market and post-market studies.
This standard ensures that:
ISO 14155 is harmonized with international regulatory bodies such as the EU Medical Device Regulation (EU MDR) and the US FDA, making it vital for global market entry and compliance.
With growing emphasis on patient safety and ethical research, regulatory authorities now demand more robust clinical trial documentation and processes for medical devices. ISO 14155:2020 bridges the gap between ethical clinical practices and business compliance.
You should adopt ISO 14155 if:
Growth Management Corporation provides complete support from gap analysis to certification readiness, making your clinical research system audit-proof and globally compliant.
Implementing ISO 14155:2020 brings a wide range of benefits, including:
ISO 14155:2020 certification and implementation offer measurable value to your medical device business. Key business advantages include:
© Growth Management Corporation. All rights reserved.